Clinical Trial Update: Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy [Phase 2]

View source ↗

Summary

Extension Phase 2 study evaluating the combination of lapatinib with trastuzumab (Herceptin) with or without endocrine therapy in breast cancer; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Tykerb (lapatinib)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2016-12-12